Advertisement
Organisation › Details
Miltenyi Biotec (Group)
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,500 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health. *
Start | 1988-01-01 splitoff | |
Predecessor | University of Cologne (Universität zu Köln) | |
Industry | BIOTECH | |
Industry 2 | magnetic cell separation technology | |
Person | Miltenyi, Stefan (Miltenyi Biotec 201404 Founder + President) | |
Person 2 | Stoffel, Boris (Miltenyi Biotec 201301 CEO before Memorec Stoffel) | |
Region | Bergisch-Gladbach | |
Country | Germany | |
Street | 68 Friedrich-Ebert-Str. | |
City | 51429 Bergisch-Gladbach | |
Tel | +49-2204-8306-0 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | F: 1,001 to 5,000 (2023-03-16) |
* Document for »About Section«: High-Tech Gründerfonds Management GmbH. (3/16/23). "Press Release: Successful Exit for HTGF. Miltenyi Biotec Acquires Biosensor Company Lino Biotech". Zurich. | ||
Record changed: 2024-04-30 |
Advertisement
More documents for Miltenyi Biotec (Group)
- [1] |transkript [Kääb, Georg]. (10/21/24). "Miltenyi Biotec: An Exclusive, Rare Interview with Founder Stefan Miltenyi. Interview by |transkript.de/Georg Kääb"....
- [2] Miltenyi Biotec B.V. & Co. KG. (9/10/24). "Press Release: Miltenyi Biotec Manufactures Lentiviral Vector for Adaptimmune’s FDA-approved TCR T-cell therapy Tecelra (afamitresgeme autoleucel)". Bergisch Gladbach....
- [3] Miltenyi Biotec B.V. & Co. KG. (4/29/24). "Press Release: Miltenyi Biotec and MiLaboratories Announce Strategic Partnership to Advance Next-generation Therapies". Bergisch Gladbach & San Francisco, CA....
- [4] Miltenyi Biotec B.V. & Co. KG. (2/27/24). "Press Release: Miltenyi Biotec Opens Its First Office in India and Plans to Invest in First of Its Kind Cell and Gene Therapy Center of Excellence". Hyderabad....
- [5] Miltenyi Biotec B.V. & Co. KG. (12/18/23). "Press Release: Miltenyi Biotec and Replay’s Oncology-focused Product Company Syena Enter into Exclusive Licensing and GMP Manufacturing Agreement for PRAME TCR-NK Cell Therapy Based on CliniMACS Prodigy". Berg...
- [6] High-Tech Gründerfonds Management GmbH. (3/16/23). "Press Release: Successful Exit for HTGF. Miltenyi Biotec Acquires Biosensor Company Lino Biotech". Zurich....
- [7] Lino Biotech AG. (3/15/23). "Press Release: Miltenyi Biotec Acquires Biosensor Company Lino Biotech". Zürich....
- [8] Leukocare AG. (11/3/21). "Press Release: Dr. Dirk Winnemöller Joins Leukocare as Vice President Commercial". Martinsried....
- [9] BIO Deutschland e. V.. (9/29/21). "Press Release: BIO Deutschland General Assembly Elects New Board in Berlin". Berlin....
- [10] Lino Biotech AG. (11/17/20). "Press Release: Lino Biotech Closes Seed Financing Round and Showcases a Novel Label-free Biosensor Platform for Innovate Modern Drug Screening". Zurich....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top